-
-
-
-
-
-
-
Paratek Pharmaceuticals (PRTK) Commences $50M Offering of Common Stock
-
-
-
-
-
-
-
BTIG Says Paratek's (PRTK) Omadacycline Phase 3 Results Support Drug as Antibiotic Treatment
10,131 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

